People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

8,045JPY
28 Aug 2015
Change (% chg)

¥331 (+4.29%)
Prev Close
¥7,714
Open
¥7,945
Day's High
¥8,056
Day's Low
¥7,865
Volume
1,652,800
Avg. Vol
1,435,245
52-wk High
¥9,756
52-wk Low
¥4,074

Search Stocks

Summary

Name Age Since Current Position

Haruo Naito

67 2014 Chief Executive Officer, Representative Executive Officer, Director

Hajime Shimizu

58 2014 Representative Executive Officer, Chief Financial Officer

Hideki Hayashi

57 2014 Representative Executive Officer, Chief Information Officer

Junichi Asatani

54 2015 Chief Compliance Officer, Executive Officer

Kenta Takahashi

55 2015 General Counsel, Managing Executive Officer

Takafumi Asano

58 2013 Senior Managing Executive Officer, President of Eisai Demand Chain Systems, President of Stable Brand DCU

Yasushi Okada

56 2014 Senior Managing Executive Officer, Chief Talent Officer, Chief Director of Human Resources Development

Edward Geary

52 2015 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

48 2014 Managing Executive Officer, President of EMEA Region, President of Eisai Global Oncology Business Unit, President & Chief Executive Officer of Subsidiary

Yuji Matsue

55 2014 Managing Executive Officer, President of Americas Region, Chairman & Chief Executive Officer of Subsidiary

Ivan Cheung

38 2014 Executive Officer, Deputy President of Eisai Global Oncology Business Unit

Frank Ciriello

54 2014 Executive Officer, President of Eisai Global Neurology Business Unit

Terushige Iike

51 2015 Executive Officer, Chief Product Creation Officer in Eisai Product Creation Systems, President of Japan/Asia Clinical Research PCU

Yasunobu Kai

53 2013 Executive Officer, President of Eisai Japan Oncology hhc Unit

Lynn Kramer

64 2013 Executive Officer, Chief Clinical Officer of Eisai Product Creation Systems, President of Neuroscience and General Medicine PCU

Kenji Matsumae

59 2015 Executive Officer, President of Integrated Community hhc Unit, President of Eisai Japan

Takashi Owa

51 2012 Executive Officer, Chief Innovation Officer

Shaji Procida

43 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

46 2015 Executive Officer

Ryohei Yanagi

52 2015 Executive Officer

Hideshi Honda

60 2014 Representative Executive Officer, President of Asia Region

Yutaka Tsuchiya

62 2014 Representative Executive Officer

Nobuo Deguchi

67 2012 Director

Hideaki Matsui

66 2011 Director

Noboru Naoe

59 2014 Director

Graham Fry

65 2012 Independent Director

Tokuji Izumi

76 2010 Independent Director

Ikuo Nishikawa

63 2014 Independent Director

Kiyochika Ohta

72 2011 Independent Director

Patricia Robinson

53 2013 Independent Director

Osamu Suzuki

65 2012 Independent Director

Toru Yamashita

67 2014 Independent Director

Hirokazu Kanai

Director of Accounting

Biographies

Name Description

Haruo Naito

Mr. Haruo Naito has been serving as Chief Executive Officer, Representative Executive Officer and Director in Eisai Co., Ltd. since June 2014. He is also working for The Naito Foundation. He joined the Company in October 1975. His previous titles include Director of Research and Development Promotion, Chief Director of Research and Development, Managing Director, Senior Managing Director, Vice President and Representative Director in the Company. He was also serving as President and Representative Director of another pharmaceutical company.

Hajime Shimizu

Mr. Hajime Shimizu has been serving as Representative Executive Officer and Chief Financial Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1981. His previous title was Managing Executive Officer, President of India Pacific Region, Director of Business Planning and Executive Officer in the Company. He also used to be Chairman of the Board, Chief Executive Officer and President in two subsidiaries, Eisai Corporation of North America and Eisai Inc.

Hideki Hayashi

Mr. Hideki Hayashi has been serving as Representative Executive Officer and Chief Information Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1981. His previous titles include Senior Managing Executive Officer, Executive Officer, Managing Executive Officer and Director of Business Development in the Company.

Junichi Asatani

Mr. Junichi Asatani has been serving as Chief Compliance Officer and Executive Officer in Eisai Co., Ltd. since April 1, 2015. He joined the Company in April 1985 and previously served as Director of Compliance & Risk Management Promotion in the Company.

Kenta Takahashi

Mr. Kenta Takahashi has been serving as General Counsel and Managing Executive Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1983 and used to serve as Executive Officer in the Company.

Takafumi Asano

Mr. Takafumi Asano has been serving as Senior Managing Executive Officer, President of Eisai Demand Chain Systems and President of Stable Brand DCU in Eisai Co., Ltd. since June 2013. He joined the Company in April 1980. His previous titles include Deputy Chief Director of Demond Chain, Director of Production Planning, Managing Executive Officer, Director of Drug Production in Misato Plant and Kawashima Plant Manager in the Company.

Yasushi Okada

Mr. Yasushi Okada has been serving as Senior Managing Executive Officer, Chief Talent Officer and Chief Director of Human Resources Development in Eisai Co., Ltd. since June 2014. He joined the Company in April 1981. His previous titles include Director of Business Planning, Director of Business Promotion in Pharmaceutical Business Unit, Director of Business Strategy in Pharmaceutical Business Unit, Managing Executive Officer and Director of Planning in Main Japan Business Main Unit in the Company.

Edward Geary

Mr. Edward Stewart Geary has been serving as Managing Executive Officer, Chief Medical Officer and Chief Director of Corporate Medical Affairs in Eisai Co., Ltd. since April 1, 2015. He joined the Company in April 1997. He was previously serving as Director of Pharmaceutical Business Policy, Executive Officer and Deputy Chief Director of Reliability Assurance in the Company. He worked for Stanford University before joining the Company.

Gary Hendler

Mr. Gary Hendler has been serving as Managing Executive Officer, President of EMEA Region and President of Eisai Global Oncology Business Unit in Eisai Co., Ltd. as well as President and Chief Executive Officer of a subsidiary, Eisai Europe Ltd., since June 2014. He used to work for another subsidiary.

Yuji Matsue

Mr. Yuji Matsue has been serving as Managing Executive Officer and President of Americas Region in Eisai Co., Ltd., as well as Chairman & Chief Executive Officer of a subsidiary, Eisai Inc., since June 2014. He joined the Company in April 1981, and previously served as Director of Investor Relations, President of Indo-Pacific Region and Director of Talent Management in Main Human Resources Development Unit in the Company.

Ivan Cheung

Mr. Ivan Cheung has been serving as Executive Officer and Deputy President of Eisai Global Oncology Business Unit in Eisai Co., Ltd. since May 2014. He joined the Company in October 2005. He used to serve as Director of Promotion in Main Product Creation Unit in CEO's Office, Deputy Chief Director of Human Resources Development and Director of Talent Management and Director of Business Strategy in the Company.

Frank Ciriello

Frank Ciriello has been serving as Executive Officer and President of Eisai Global Neurology Business Unit in Eisai Co., Ltd. since April 1, 2015. Ciriello used to work for Eisai Inc.

Terushige Iike

Mr. Terushige Iike has been serving as Executive Officer, Chief Product Creation Officer in Eisai Product Creation Systems and President of Japan/Asia Clinical Research PCU in Eisai Co., Ltd. since April 1, 2015. He joined the Company in April 1986.

Yasunobu Kai

Mr. Yasunobu Kai has been serving as Executive Officer and President of Eisai Japan Oncology hhc Unit in Eisai Co., Ltd. since April 2013. He joined the Company in April 1986. He used to be President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Lynn Kramer

Lynn Kramer has been serving as Executive Officer, Chief Clinical Officer of Eisai Product Creation Systems and President of Neuroscience and General Medicine PCU in Eisai Co., Ltd. since April 2013. Kramer used to work for Eisai Inc.

Kenji Matsumae

Mr. Kenji Matsumae has been serving as Executive Officer, President of Integrated Community hhc Unit and President of Eisai Japan in Eisai Co., Ltd. since April 1, 2015. He joined the Company in April 1981.

Takashi Owa

Mr. Takashi Owa has been serving as Executive Officer and Chief Innovation Officer in Eisai Co., Ltd. since June 2012. He joined the Company in April 1991. He used to be Director of 2nd Drug Development Research Institute and President of Oncology Drug Development Unit in the Company.

Shaji Procida

Shaji Procida has been serving as Executive Officer in Eisai Co., Ltd., as well as President and Chief Operating Officer of a subsidiary, Eisai Inc., since April 1, 2015. Procida used to work for another company.

Sayoko Sasaki

Ms. Sayoko Sasaki has been serving as Executive Officer in Eisai Co., Ltd. since April 1, 2015. She joined the Company in April 1991.

Ryohei Yanagi

Mr. Ryohei Yanagi has been serving as Executive Officer, Chief IR Officer and Deputy Chief Financial Officer in Eisai Co., Ltd. since April 1, 2015. He joined the Company in September 2009.

Hideshi Honda

Mr. Hideshi Honda has been serving as Representative Executive Officer and President of Asia Region in Eisai Co., Ltd. since June 2014. He joined the Company in April 1977. His previous titles include Managing Executive Officer, Director of International and Business development, Executive Officer, Deputy Chief Director of Global Pharmaceutical, Vice President, President of East Asia Region and Deputy Director of Cosmetic Medicine in the Company.

Yutaka Tsuchiya

Mr. Yutaka Tsuchiya has been serving as Representative Executive Officer in Eisai Co., Ltd. since June 2014. He joined the Company in April 1975. His previous positions include Executive Officer, Director of Planning in Clinical Test Research Center, Managing Executive Officer, Senior Managing Executive Officer and Chief Director of Reliability Assurance in the Company. He also used to be Chairman of the Board and Chief Executive Officer in an United Kingdom-based subsidiary.

Nobuo Deguchi

Mr. Nobuo Deguchi has been serving as Director in Eisai Co., Ltd. since June 2012. He joined the Company in March 1970. His previous titles include Vice President, Chief Compliance Officer, Representative Executive Officer, Senior Managing Executive Officer, Director of Internal Control Promotion, Executive Officer and Managing Executive Officer in the Company, as well as President and Representative Director in a subsidiary.

Hideaki Matsui

Mr. Hideaki Matsui has been serving as Director in Eisai Co., Ltd. on June 2011. He is also a member of Audit Committee of the Company. He joined the Company in March 1971. His previous titles include Director of Business Planning, Executive Officer, Managing Executive Officer, Senior Executive Officer, Chief Financial Officer, Senior Managing Executive Officer, Chief Director of Finance & Accounting and Representative Executive Officer in the Company. He used to be Chairman of a fund of Eisai.

Noboru Naoe

Mr. Noboru Naoe has been serving as Director in Eisai Co., Ltd. since June 2014. He joined the Company in April 1978. His previous titles include Executive Officer, Deputy Director of Pharmaceutical Business, Director of Medicine Business, Senior Director of Medicine in Main Japan Business Unit, Managing Executive Officer and President of Eisai Japan in the Company.

Graham Fry

Mr. Graham Fry has been serving as Independent Director in Eisai Co., Ltd. since June 2012. He is also a member of Nominating Committee, and Chairman of Compensation Committee of the Company. He is also working for University of London. He used to work for British Foreign & Commonwealth Office.

Tokuji Izumi

Mr. Tokuji Izumi has been serving as Independent Director in Eisai Co., Ltd. since June 2010. He is also working for TMI Associates. He used to work for Tokyo District Court, Kanazawa District Court, the Supreme Court and Tokyo High Court.

Ikuo Nishikawa

Mr. Ikuo Nishikawa has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is also Chairman of Audit Committee of the Company. He is also working for Nidec Corporation. He is also a professor of Keio University, He used to work for Ernst & Young ShinNihon LLC.

Kiyochika Ohta

Mr. Kiyochika Ohta has been serving as Independent Director in Eisai Co., Ltd. since June 2011. He is also Chairman of Nominating Committee, and a member of Compensation Committee of the Company. He is also working for Canon MJ IT Group Holdings Inc. He used to serve as Vice Chairman of the Board, Vice President and Representative Director in Nomura Research Institute, Ltd., as well as President and Representative Director in Canon IT Solutions Inc.

Patricia Robinson

Patricia Robinson has been serving as Independent Director in Eisai Co., Ltd. since June 2013. Robinson is also a member of the Audit Committee of the Company. Robinson is also Associate Professor of Hitotsubashi University.

Osamu Suzuki

Mr. Osamu Suzuki has been serving as Independent Director in Eisai Co., Ltd. since June 2012. He is also a member of Audit Committee of the Company. He is also serving as Partner of YUASA AND HARA. He used to serve as Independent Director in Yamada Corporation.

Toru Yamashita

Mr. Toru Yamashita has been serving as Independent Director in Eisai Co., Ltd. since June 2014. He is a member of Nominating and Compensation Committees of the Company. He is also serving as Independent Director in Mitsui Fudosan Co., Ltd., and working for NTT DATA CORPORATION. He used to work for Nippon Telegraph and Telephone Public Corporation.

Hirokazu Kanai

Search Stocks